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Abstract 
To our knowledge this is the first study to rigorously explore salivary cytokines in youth. 
Cytokines in saliva and serum were analyzed across three annual assessments in healthy 
adolescent girls (N=114, 11-17 years at enrollment). We assayed saliva for GM-CSF, IFNγ, IL-
1ß, IL-2, IL-6, IL-8, IL-10, IL-12p70, TNFα, adiponectin, and cotinine. Results revealed: (1) 
cytokine levels, except IFNγ and IL-10, were detectable in saliva, and salivary cytokine levels, 
except IL-8 and IL-1ß, were lower than serum levels; (2) salivary cytokine levels were lower in 
older girls and positively associated with adiponectin; (3) compared to serum cytokines, the 
correlations between salivary cytokines were higher, but salivary cytokines were less stable 
across years; and (4) only IL-1ß in one assessment year showed a significant serum-saliva 
association. Variation in basal salivary cytokines in healthy adolescent girls largely reflects 
compartmentalized activity of the oral mucosal immune system, rather than systemic cytokine 
activity.  
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Introduction 
More so than any other time in the history of developmental science, the direction of 
child and adolescent research is being influenced by theoretical models that emphasize the 
confluence of biological, behavioral, social, and contextual forces in child development and 
health. Our understanding of the mechanisms linking the central and peripheral nervous and 
immune systems have evolved significantly, leading researchers to consider the nature and 
implications of effects of these systems on behavior, immunity, illness susceptibility, and 
negative health outcomes. However, generally speaking, how these relationships affect child and 
adolescent health and development has received only scant empirical attention (e.g., Granger, 
Kivlighan, Blair, El–Sheikh, Mize, Lisonbee, & Schwartz, 2006).  
Technical advances now enable minimally invasive measurement (in saliva) of many of 
the intracellular regulatory molecules (i.e., cytokines) responsible for linking communications 
between the immune system and the central nervous system (CNS), hypothalamic-pituitary-
adrenal (HPA) axis, and behavior (Granger, Fortunato, Beltzer,Virag, Bright, & Out, 2012). To 
date, with a few exceptions (El-Sheikh, Buckhalt, Granger, Erath, & Acebo, 2007; Keller, El-
Sheikh, Vaughn, & Granger, 2010) the depth of our knowledge regarding the nature and 
meaning of individual differences in salivary cytokine levels in youth is extraordinarily shallow. 
Basic questions related to observed variation, intercorrelations between cytokines, stability over 
time, and the correlates and concomitants of salivary cytokine measurements in youth remain 
unanswered. In the present study, we begin to address several knowledge gaps by analyzing 
cytokines reflecting various components of intercellular and hormonal signaling within the 
neuro-endocrine-immune (NEI) network in saliva samples, which were collected across three 
years of annual assessments in a multi-cohort prospective study of healthy adolescent girls.  
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Conceptual Issues 
The Neuro-endocrine-immune (NEI) Network. The history of science linking behavior 
and psychological states to changes in immune function is well documented (see Ader, 1996, 
2000 for reviews). The first era spans the turn of the prior century through the 1950s. During this 
period, the field of immunology expanded our understanding of lymphoid cell and tissue 
function, antibody specificity and activity, and most other basic features of the immune system. 
Since the CNS lacks a lymphatic system to drain its tissues and capture potential antigens, it was 
assumed the CNS was protected from infiltration of many soluble substances (e.g., cytokines) 
and the inward migration of lymphoid cells by the blood-brain barrier. Correspondingly, it was 
widely held that the CNS operated relatively isolated from and independent of the immune 
system. Evidence supporting the veridicality of an immune-CNS link was not reported until the 
1970-80s when anatomical pathways were discovered that physiochemically linked the CNS and 
lymphoid systems. Based on these findings, it was established that the HPA axis and autonomic 
nervous system (ANS) were able to communicate with and alter the function of lymphoid cells 
by releasing factors and hormones secreted into general circulation (see Ader, 2000 for review). 
These discoveries established the scientific legitimacy of studying interrelationships among the 
brain, behavior, and immunity. 
Before the 1960-70s, it was assumed that cellular communication within the immune 
system depended largely on cell-to-cell contact. However, a series of landmark studies (e.g., 
Granger & Williams, 1968; Hessinger, Daynes, & Granger, 1973) revealed that lymphoid cells 
secreted soluble chemical messengers to initiate, maintain, and regulate cellular immune 
responses. Later it was discovered that these soluble signals (see Maier & Watkins, 1998; Smith, 
1992; Vilcek, 1998) also had “hormonal” effects on nonlymphoid cells (e.g., Besedovsky, del 
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Rey, Sorkin, Da Prada, Burri, & Honegger, 1983; Besedovsky & del Rey, 1989). In recognition 
of their functional diversity, this group of signaling molecules was designated cytokines (see 
below for more detail) in the 1980s.  
For researchers interested in the interactions between the brain, behavior, and immunity, 
this set of discoveries completed a critically important communication loop. That is, cells of the 
lymphoid, CNS, and endocrine systems use the same hormones, neurotransmitters, and other 
critical effector molecules to send and receive signals among one another. Thus, the central 
nervous, endocrine, and immune systems constitute an interactive information network, with 
each node capable of affecting and being affected by the activity of the others (Ader, 2000; 
Black, 1995; Cotman, Brinton, Glaburda, McEwen, & Schneider, 1987).  
Decoding the syntax of these communications has enabled theorists to attribute new 
features to the immune system’s functional repertoire. Blalock (e.g., 1994, 1997) proposed that 
the immune system recognizes unique environmental stimuli (e.g., viruses, bacteria, microbes, 
toxins) that are essentially undetectable by our classic sensory systems. Just as is true with our 
other sensory inputs, when the immune system recognizes such stimuli, the encounter is 
converted into a cascade of biochemical messages. We now know that those messages are 
responsible for inducing changes in the host’s metabolic, thermogenic, and behavioral states in 
response to infection. Characterizing the immune system as a “sixth sense” (Blalock, 1994; 
1997) highlights the biological plausibility that communications between the immune system and 
the brain represent a largely unexplored pathway through which environmental factors (non-self 
antigens) shape and reshape the structure and function of the biological systems underlying 
behavior.  
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Primer on Cytokines for Developmental Scientists. Cytokines are protein molecules that 
act as intercellular messengers which range in size from 8 to 30 kiloDaltons (kDa) and induce 
their effects by binding to high-affinity receptors on target cell membranes. Monocytes and 
macrophages are especially efficient cytokine producers. Most cytokine secretion involves de 
novo protein synthesis, a process that takes hours. Cytokines play important roles in maintaining 
health and are the causative agents in disease. In addition to regulating immune and 
inflammatory responses, the biologic consequences of cytokine signaling are critical for 
development, growth, healing, and maintenance of just about every tissue and organ of the body.  
Cytokines can be grouped into families according to their structure, common receptor 
usage, and whether they have predominantly anti-inflammatory, proinflammatory, chemotactic, 
or growth-promoting functions. Within the immune system, in general, interleukins (e.g., IL-1ß, 
IL-2, IL-6, IL-8, IL-10, IL-12p70) are molecules that have a functional activity involving 
leukocytes; colony-stimulating and growth factors (e.g., GM-CSF) promote cell proliferation of 
hematopoeitic and somatic cells; tumor necrosis factors (e.g., TNFα) initiate inflammation, 
orchestrate the development and maintenance of lymphoid organs, and regulate lymphocyte 
homeostasis and proliferation; interferons (e.g., IFNγ) act to interfere with viral replication; and 
chemokines are chemotactic agents that recruit leukocytes to sites of inflammation and 
orchestrate lymphoid architecture and leukocyte trafficking (Clough & Roth, 1998). Cytokines 
are extremely potent, and their presence even at very low pg/ml levels can induce substantial 
cellular consequences. A complex set of mechanisms exists to prevent cytokines from doing 
damage to the host. Inadequate production of cytokines will result in an insufficient cellular 
immune response and a potentially negative outcome related to pathogenesis of the microbe or 
virus. On the other hand, excessive cytokine secretion has been linked to “sickness behaviors” 
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(see subsequent discussion), autoimmune disorders (e.g., arthritis), neurological disease (e.g., 
multiple sclerosis), toxic shock, and death (see reviews by Goldsby, 2003; Thomson & Lotze, 
2003). 
Peripherally Activated Cytokines Communicate with the CNS, HPA, and ANS. The most 
well-characterized pathway through which peripheral immunological stimuli signal changes in 
the brain begins with the macrophage. When activated, macrophages secrete a cascade of 
cytokines. The cytokine products released in response to immune stimulation, not the direct 
effect of the immunological stimulus (e.g., bacterial or viral pathogenesis), are particularly 
important for mediating many of the resulting changes in the brain (Dantzer, Bluthe, & Goodall, 
1993; Dinarello, 1984a, 1984b). Molecular, cellular, and in vivo evidence suggests that 
macrophage-derived interleukin-1 (IL-1ß) has the most systemic and hormonal-type effects of all 
the cytokines (Smith, 1992), with widespread consequences for the brain (Weiss, Quan, & 
Sundar, 1994). Peripheral administration of IL-1ß stimulates corticotropin-releasing factor (CRF) 
from hypothalamic neurons (Harbuz & Lightman, 1992; Sapolsky, Rivier, Yamamoto, Plotsky, 
& Vale, 1987; Woolski, Smith, Meyer, Fuller, & Blalock, 1985), resulting in increased 
circulating levels of ACTH and corticosterone (Dunn, 1988, 1990). IL-6 and TNFα function 
similarly to IL-1ß in that they also stimulate the HPA axis during inflammatory stress (Smith, 
1992).  
 Cytokines have a variety of effects on cerebral neurotransmission (see Dunn & Wang, 
1995; Dunn, Wang, & Ando, 1999). IL-1ß stimulates cerebral norepinephrine (NE) metabolism. 
Together with IL-6 and TNFα, IL-1ß also stimulates indolamine metabolism of tryptophan and 
decreases the concentration of serotonin. Cytokine-stimulated indolamines also affect the 
synthesis of quinolinic (QUIN) and kynurenic acid. In the brain, QUIN is an agonist of 
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excitatory amino acid receptors, including the N-methyl-d-aspartate (NMDA) receptor. 
Prolonged activation of these excitatory amino acid receptors in the hippocampus, basal ganglia, 
and cerebral cortex may damage the nerve cells. In addition to CNS effects of peripheral 
cytokines, brain cells can release cytokines, and communication between the CNS and immune 
system is mediated via a direct connection by the vagus nerve (Heyes, 1992; Heyes, Brew, Saito, 
Quearry, Price, Lee, Bhalla, Der, & Markey, 1992; Heyes, Quearry, & Markey, 1989; Heyes, 
Saito, et al., 1992; Saito, Markey, & Heyes, 1992).  
The effects of cytokines involve changes in neurotransmission in brain regions important 
for learning and memory, emotion regulation, and the psychobiology of the stress response (i.e., 
limbic system, hypothalamus) (e.g., Hart, 1988; Moldawer, Andersson, Gelin, & Lundholm, 
1988; Opp, Orbal, & Kreuger, 1991; Sparado & Dunn, 1990; Avitsur & Yirmiya, 1999; Dantzer, 
2001). Tyrell and colleagues (Smith, Tyrell, Al-Nakib, Coyle, Donovan, Higgings, & Willman, 
1987; Smith, Tyrell, Coyle, & Higgins, 1988; Smith, Tyrell, Coyle, & Willman, 1987) extended 
these findings to humans by rigorously documenting the adverse effects of experimentally-
induced respiratory virus infection and cytokine administration on psychomotor performance, 
mood, and memory.  
Cytokines in Saliva  
The immune system is organized into anatomically discrete compartments to respond to 
pathogens present in different body tissues (e.g., blood, mucosal surfaces, intestines, and 
airways). It is well known that variation in localized immune responses is largely confined to that 
particular compartment and relatively independent of the more general systemic level of immune 
activation (e.g., Kindt, Osborne, & Goldsby, 2006). Therefore, unlike many commonly 
investigated salivary analytes such as cortisol, the vast majority of variation in cytokines in oral 
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fluid may be produced locally in the oral cavity (Granger et al, 2006). To the extent this is true, 
the measurement of salivary cytokine levels may be of questionable value to the study of brain, 
behavior, and immunity. Consistent with this possibility, and in contrast to the strong serum-
saliva associations for many endocrine markers, in studies with adults the serum-saliva 
correlations for immune markers has been shown to be small to modest (e.g., Nishanian, Aziz, 
Chung, Detels, & Fahey, 1998). Serum-saliva correlations for immune markers in children and 
adolescents, however, are unknown.  
The Present Study 
To our knowledge this is the first study to rigorously and systematically explore the 
nature, variation, and correlates of salivary cytokines in youth. Saliva samples were collected 
across three annual assessments in a multi-cohort prospective study of healthy girls aged 11 to 17 
years at the first assessment. Samples were assayed for a representative panel of nine cytokines 
(GM-CSF, IFNγ, IL-1ß, IL-2, IL-6, IL-8, IL-10, IL-12p70, TNFα) reflecting various components 
of intercellular and hormonal signaling within the NEI network. We examine the amount of 
variation, intercorrelations, and stability over time in salivary cytokines. Given the expectation 
that salivary cytokine levels may reflect local-oral mucosal immune activation, we also 
examined associations between cytokines and an salivary adipokine (adiponectin) related to 
periodontal health (Iwayama, Yanagita, Mori, Sawada, Ozasa, Kubota, Miki, Kojima, Takedachi, 
Kitamura,  Shimabukuro, Hashikawa, & Murakami., 2012) and controlled for smoking, a health 
behavior prevalent during adolescence and known to compromise oral health. Further, matching 
serum cytokine levels were employed to evaluate serum-saliva associations. In these analyses, 
we controlled for smoking and salivary adiponectin to test the hypothesis that controlling for oral 
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health improves serum-saliva associations for markers that are at least partly influenced by oral 
health.  
Methods 
Participants 
   This investigation analyzed data from a longitudinal study designed to examine the 
impact of depressive symptoms and substance use on reproductive and bone health across 
puberty in girls (Dorn, Pabst, Sontag, Kalkwarf, Hillman, & Susman 2011; Hillman, Dorn, & 
Huang, 2010). Using a cross-sequential design (Donaldson & Horn, 1992), a total of 262 girls 
were enrolled and grouped in four cohorts depending on their age at the first assessment. The 
first cohort consisted of girls aged 11 years (cohort 11), the girls in the second cohort were 13 
years old (cohort 13), the third cohort included girls aged 15 (cohort 15) and the girls in the 
fourth cohort were 17 years old (cohort 17). Each cohort was assessed annually for three 
consecutive years. Enrollment took place between December 2004 and October 2007. Girls were 
recruited from a teen health clinic in a children’s hospital in a Midwestern city and its 
surrounding community. Exclusion criteria for enrollment in the larger study included: 1) 
pregnancy or breast feeding within 6 months, 2) primary amenorrhea (> 16 years), 3) secondary 
amenorrhea (< 6 cycles/year; not due to hormone contraception), 4) body mass index (BMI) < 1st 
percentile or weight > 300 pounds, 5) medication/medical disorder influencing bone health (e.g., 
prednisone, seizure medications), and 6) psychological or cognitive disabilities impairing 
comprehension or compliance.  
Annual assessments of salivary data were analyzed for a subset of girls selected from the 
larger study who had complete salivary and serum cytokine data (complete data available for 113 
girls at year 1, 114 girls at year 2, and 107 girls at year 3). The mean age at the first assessment 
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was 11.35 years (SD = 0.27) for cohort 11, 13.52 (SD = 0.42) for cohort 13, 15.59 (SD =0.30) 
for cohort 15, and 17.66 (SD = 0.25) for cohort 17. The majority of the sample was Caucasian 
(78% for cohort 11, 64% for cohort 13, 58% for cohort 15, 68% for cohort 17). Socioeconomic 
status, measured with Hollingshead criteria, averaged 44.33 (SD =11.78) for cohort 11, 42.68 
(SD = 12.80) for cohort 13, 32.21 (SD = 14.33) for cohort 15, and 39.92 (SD = 12.18) for cohort 
17. The study was approved by the Institutional Review Board of the children’s hospital. Written 
parental consent was obtained, and each adolescent provided assent.  
Procedure 
Data were collected in a Clinical Translational Research Center (CTRC). Lab visits were 
conducted between 11:30 A.M. and 12:30 P.M. and consisted of a physical examination, 
anthropometry, blood and saliva sampling, psychosocial questionnaires and interviews, and bone 
densitometry. Girls were instructed to fast for the two hours preceding their visit to the lab. If a 
participant was menarcheal researchers attempted to reschedule her visit to day 5-9 of her 
menstrual cycle. Lab visits were also rescheduled if girls reported an infection or acute illness. 
Saliva samples were collected using Salivettes (Sarsted, NC). For more details regarding the 
procedures, see Dorn and colleagues (2011). 
Measures 
Puberty. Pubertal maturation was determined by physical examination carried out by 
trained clinicians using visualization and breast palpation and inspection of pubic hair and was 
categorized by Tanner criteria (Marshall & Tanner, 1969).  
Smoking. Smoking behavior was first determined by questionnaire asking participants to 
describe their current smoking behavior (i.e., if she had never smoked, tried smoking, used to 
smoke but stopped, or was currently smoking) (Mayhew, Flay, & Mott, 2000). In addition, 
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tobacco smoke exposure was tested by assaying the saliva samples for cotinine (a primary 
metabolite of nicotine) using a commercially available enzyme immunoassay without 
modification to the manufacturers protocol (Salimetrics, State College, PA). The test used 20 μl 
of sample, had a lower limit of sensitivity of .05 ng/mL, a range of sensitivity from .05 to 200 
ng/mL and an average intra-assay coefficient of variability (CV) of less than 8%. Salivary 
cotinine was recoded into groups based on reported cutoffs for smoking status (low/non-smoker= 
0-15 ng/mL; smoker > 15 ng/mL) (Etzel, 1990; Jarvis, Tunstall-Pedoe, Feyerabend, Vesey, & 
Salooiee, 1987; Patrick, Cheadle, Thompson, Dieher, Koepsell, & Kinne, 1994). All adolescents 
with cotinine levels higher than 15 ng/mL and adolescents who reported that they smoked 
(irrespective of their cotinine levels) were categorized as “smokers”.  Adolescents with low 
cotinine levels (≤ 15 ng/mL) and who also reported that they did not smoke were categorized as 
“non-smokers”. Approximately one quarter of the girls were smokers (year 1: 23% of girls were 
smokers (26/113); year 2: 22% smokers (25/114); year 3: 27% smokers (29/107)).  
Determination of salivary cytokines. Salivary cytokines were measured using 96-well 
format multiplex electrochemiluminescence immunoassays manufactured by Meso Scale 
Discovery (MSD, Gaithersburg, MD). Each well of each 96-well plate is coated with capture-
antibodies to GM-CSF, IFNγ, TNFα, IL-1ß, IL-2, IL-6, IL-8, IL-10 and IL-12p70. Detection 
antibodies are coupled to SULFOTAGTM labels that emit light when electrochemically 
stimulated via carbon-coated electrodes in the bottom each microwell. The MSD 9-plex Multi-
Spot Array assay was run following the manufacturers recommended protocol without 
modification. Cytokine concentrations (pg/mL) were determined with MSD Discovery 
Workbench Software (v. 3.0.17) using curve fit models (4-PL with a weighting function option 
of 1/y2). Lower limits of detection (LLD) and intra-assay coefficients of variation (CV) were as 
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follows: GM-CSF (0.26 pg/mL, 14%), IFNγ (3.04 pg/mL, 17%), TNFα (0.58 pg/mL, 12%), IL-
1ß (0.58 pg/mL, 6%), IL-2 (0.39 pg/mL, 13%), IL-6 (0.21 pg/mL, 12%) , IL-8 (0.15 pg/mL, 
12%), IL-10 (1.01 pg/mL, 8%), and IL-12p70 (0.48 pg/ml, 14%).   
Determination of salivary adiponectin. Adiponectin is an endocrine factor secreted by 
adipose tissue. Studies show adiponectin plays a role in inflammation and immune responses and 
has a potent beneficial function on the maintenance of the homeostasis of periodontal health 
(Iwayama, et. al, 2012; Kraus, Winter, Jepsen, Jager, Meyer, & Dreschner, 2012). We assayed 
adiponectin using an enzyme immunoassay designed for use with serum (Duoset, R&D Systems, 
MN) modified for use with saliva. Samples were assayed at a 1:8 dilution (35uL volume of 
saliva was diluted), test volume was 100ul, standard curve ranged from 62.5 to 2000 pg/mL, and 
inter-assay CVs were on average 4.56%. A subset of samples were re-assayed at 1:4 (34/334 
samples) or 1:16 (5/334 samples) based on values returned at 1:8 that were below or above the 
standard curve.  
Serum cytokine determinations. As part of the larger study, the cytokine panel assayed in 
saliva (described above) had been previously measured in serum using the Luminex platform and 
LincoplexTM methodology without modification to the manufacturers recommended protocol 
(Millipore, Billerica, MA). For the serum cytokines, sensitivities were: GM-CSF (0.46 pg/mL), 
TNFα (0.05 pg/mL), IL-1ß (0.06 pg/mL), IL-2 (0.16 pg/mL) IL-6 (0.10 pg/mL), IL-8 (0.11 
pg/mL), IFNγ (0.29 pg/mL, IL-10 (0.15 pg/mL), and IL-12p70 (0.11 pg/mL) with intra-assay 
CVs ranging from 3.11- 5.86% (see Dorn, Hillman, Houts, Denson, & Pabst, submitted).  
Analytic Strategy 
A log transformation was applied to all salivary and serum cytokines in order to correct 
for the positively skewed distribution. Any remaining outliers were winsorized (Tabachnik & 
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Fidell, 2001); that is, all values higher than three standard deviations from the mean were 
replaced with the next highest value in the distribution. The main analyses were conducted using 
the transformed and winsorized variables. To simplify the presentation, the main analyses report 
findings from the first assessment year, and results for the second and third assessment years are 
described only if they differ from those of the first year. 
 Paired t-tests were conducted to test whether cytokine levels in saliva were significantly 
different as compared to serum levels. Developmental differences in salivary cytokine 
concentrations were examined within each assessment year by Pearson’s correlations (to 
examine the relation with age) and independent t-tests (to examine the relation with pubertal 
stage). Since very few girls were in Tanner Breast Stages 1-4 (34% for assessment year 1, 22% 
for year 2, and 12% for year 3), we compared levels of salivary cytokines between girls in stages 
1-4 and girls in stage 5. The intercorrelations between serum cytokines and between salivary 
cytokines were examined by calculating partial correlations (controlling for age) and by principal 
component analyses (PCA) with promax rotation. Stability in cytokine levels over time and the 
associations with adiponectin were also evaluated using partial correlations (controlling for age).  
 Finally, serum-saliva associations for each of the cytokines were examined by calculating 
partial correlations (controlling for age). Then, hierarchical regression analyses were conducted 
to test whether controlling for age, smoking status, and adiponectin improved the associations 
between salivary and serum levels of the cytokines within each assessment year. For each 
salivary cytokine, a regression analysis was performed with age, adiponectin and smoking status 
in the first step and the serum levels of the respective cytokine in the second step. Although the 
transformation and winsorizing improved the distributions of the salivary and serum cytokines 
substantially, there was still modest positive skewness for some of the variables. Therefore, 
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robust regression analyses were performed, which are designed to be not overly affected by 
violations of assumptions for least squares regression (e.g., normal distribution, absence of 
outliers, absence of heterogeneity). 
Results 
Descriptive statistics for salivary and serum cytokine levels 
Descriptive statistics (means, standard deviations, minimum and maximum, medians and 
25% and 75% percentiles) are presented in Table 1, separately for each salivary cytokine and 
assessment year, but averaged across age-cohort. Similarly, descriptive statistics for the serum 
cytokines can be found in Table 2. With the exception of IL-10 and IFNγ, salivary levels were 
above the lower limit of detection (LLD) in the majority of samples for each cytokine 
(percentage of values below LLD: 0 – 49%). Values below the LLD were replaced with zeros, so 
as to be consistent with previous reports on this sample (Dorn et al., 2011). Salivary IL-10 and 
IFNγ were excluded from further analyses, because across all assessment years and age-cohorts 
(a total of 334 samples), 80% and 64% of samples had levels below the LLD for IFNγ and IL-10 
respectively.  
Within each assessment year, paired t-tests were conducted to examine whether cytokine 
levels in saliva were significantly different than serum levels. For the first assessment year, 
results indicated that salivary levels were significantly lower than those in serum (p’s <.01), 
except for levels of IL-1β and IL-8 which had salivary levels greater than serum levels (p’s 
<.01). Results were similar for years 2 and 3 with the exception of year 3 concentrations of IL-8 
(p = .08) and GM-CSF (p =.13) which were not significantly different in serum and saliva.  
Within each assessment year, Pearson’s correlations were calculated to examine 
developmental differences by age in salivary cytokines. With the exception of IL-1β at years 1 
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and 2 and IL-6 at year 2, older girls had lower levels of all salivary cytokines at years 1 and 2 
(for year 1: r [111] = -.40 – -.24, p’s <.02; for year 2: r [112] = -.34 – -.20, p’s <.04). At year 3, 
however, there were no significant correlations between age and salivary cytokine levels.  
Independent t-tests examining differences in salivary cytokine levels between early 
(Tanner Breast Stages 1-4 (year 1, n = 38; year 2, n = 25; year 3, n = 13)) and late (Tanner Breast 
Stage 5 (year 1, n =75; year 2, n = 88; year 3, n = 93)) pubertal development showed similar 
findings. Lower cytokine concentrations in saliva were associated with more mature pubertal 
stage for most cytokines in assessment years 1 and 2 (for year 1 (n = 113), p’s <.01 for all 
cytokines except IL-12p70 which showed no association with pubertal stage (p = .09); for year 2 
(n = 113), p’s < .04 except for IL-6 and IL-1β which showed no association with pubertal stage, 
p = .32 and p = .12, respectively). In contrast, only IL-8 (p = .02) and GM-CSF (p <.01) were 
significantly related to pubertal stage at year 3 (n = 106), with more advanced puberty associated 
with lower levels of these cytokines in saliva.  
------------------------------------------- 
Insert Tables 1 and 2 about here 
------------------------------------------- 
Intercorrelations of cytokines  
Salivary cytokines were strongly and positively intercorrelated (all p’s < .01; Table 3) for 
the first assessment year, with partial correlations (controlling for age) ranging between .51 (df = 
110, p < .01) and .93 (df = 110, p < .01). A PCA pointed to one underlying component, 
explaining 75% of the variance in saliva cytokine levels. Standardized component loadings 
ranged between .77 and .95. Results were similar for the second and third year: partial 
correlations ranged between .42 (df = 111, p <.01) and .92 (df = 111, p < .01) for the second year 
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and between .39 (df = 104, p < .01) and .87 (df = 104, p < .01) for the third assessment year. 
Similarly, the PCAs for the second and third years also pointed to one underlying component 
explaining 72% and 65% of the variance in salivary cytokines, respectively.  
By contrast, for serum cytokines, most of the partial correlations were modest (see Table 
3) at the first assessment year, ranging between .20 (df = 110, p = .03) and .89 (df = 110, p < 
.01). A PCA with promax rotation was performed and results pointed to two underlying 
components which explained in total 73% of the variance. The first component included the 
cytokines IL-12p70, IL-1β, IL-2, IL-6, and GM-CSF (standardized component loadings between 
.74 and .87), whereas the second component consisted of IL-8 and TNFα (standardized 
component loadings: .63 and .75, respectively). For the second and third assessment years, 
partial correlations were comparable, ranging between .10 (IL-12p70 and TNFα, df = 111, p = 
.31) and .82 (IL-1β and IL-2, df = 111, p<.01) for the second year and between -.11 (IL-8 and 
GM-CSF, df = 104, p = .25) and .69 (IL-2 and IL-6, df = 104, p <.01) for the third year. A PCA 
with promax rotation for year 2 concentrations revealed a similar component structure to year 1 
cytokines; 69% of the variance was explained by two underlying components each made up of 
the same cytokines groupings as year 1 cytokines. A PCA with promax rotation for year 3 
cytokines also pointed to 2 components explaining 73% of the variance. However, unlike 
assessment years 1 and 2, in year 3 IL-12p70, IL-2, IL-6, IL-8 and TNFα loaded on the first 
component (standardized component loadings between .64 and .89), and IL-1β and GM-CSF 
loaded on the second component (standardized component loadings: .75 and .78, respectively). 
------------------------------------------- 
Insert Table 3 about here 
------------------------------------------- 
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Stability of individual differences in cytokines across assessment years 
As can be seen in Table 4, salivary cytokines were modestly associated over time. On 
average, the size of the partial correlation (controlling for age) for the stability across a one-year 
period was .30 (assessment years 1 and 2; r [110] = .21 - .38, p’s < .05) and .25 (years 2 and 3; r 
[104] = .09 - .36, p = .34 - <.01). The coefficients for the stability across a two-year period 
averaged .34 (r [103] = .19 - .46, p’s = .06 - <.01). No specific salivary cytokine was necessarily 
more stable across time than any other. By contrast, for serum cytokines the size of the 
coefficients between assessment years 1 and 2, years 2 and 3, and years 1 and 3 were, on average 
.61 (r [110] = .39 – .75, p’s < 01), .33 (r [104] = .10 - .54, p = .32 - <.01) and .40 (r [103] = .16 - 
.57, p = .09 - <.01), respectively. Noteworthy is the observation that individual differences in 
levels of IL-12p70, IL-1β, IL-2, and IL-6 were more stable over time when measured in serum 
than in saliva.  
------------------------------------------- 
Insert Table 4 about here 
------------------------------------------- 
Cytokines and salivary adiponectin  
 Table 5 presents correlation coefficients for the association between salivary adiponectin 
and each salivary and serum cytokine, controlling for age, at the first assessment year. For every 
salivary cytokine, there was a significant and strong positive association between cytokine level 
and adiponectin (r [110] = .46 - .77, p’s < .01). In striking contrast, there was no significant 
association between salivary adiponectin and any cytokine measured in serum (r [110] = -.08 – 
.00, p’s = .38 – > 1.00). Results were similar for the second and third assessment years.  
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------------------------------------------- 
Insert Tables 5 and 6 about here 
------------------------------------------- 
 
Serum-saliva associations  
No significant saliva-serum correlations were found for any cytokine in assessment year 
1 (r [110] = -.11 - .11, p’s = .24 - .92; Table 6), and similar results were found for years 2 and 3. 
Hierarchical regressions revealed that the predictors from the first step (age, adiponectin and 
smoking status) significantly predicted levels of salivary IL-12p70 (F [3, 109] = 19.30, p <.01), 
IL-1β (F [3, 109] = 61.12, p <.01), IL-2 (F [3, 109] = 51.78, p <.01), IL-6 (F [3, 109] = 19.56, p 
<.01), IL-8 (F [3, 109] = 74.03, p <.01), TNFα (F [3, 109] = 25.27, p <.01), and GM-CSF (F [3, 
109] = 50.83, p <.01) in the first assessment year (Table 7). For all salivary cytokines, 
adiponectin was significantly associated with cytokine levels (t = 5.80 – 14.73, p’s < .01). Older 
girls had significantly lower levels of IL-8, TNFα and GM-CSF (t = -3.43 – -2.35, p’s < .03), and 
this association was marginally significant for IL-2 (t = -1.96, p = .05). Also, current smokers 
had lower levels of GM-CSF (t = -2.46, p =.02) and marginally lower levels of IL-6 (t = -1.87, p 
= .06). In contrast, for all cytokines, serum levels of the respective cytokine did not significantly 
predict salivary levels after controlling for age, adiponectin and smoking status in the first 
assessment year (t = -0.87 – 1.61, p’s > .05).  
Results were similar for the second and third assessment year. However, differences 
between years were seen in the relation between smoking status and salivary cytokine 
concentrations. IL-1β was higher in smokers than non-smokers in year 2 (t = 2.67, p <.01), and 
IL-1β, IL-2 and IL-6 (t = 2.24 - 3.17, p < .03) were higher in smokers than non-smokers in year 
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3. Also, in addition to the age effects seen at year 1, at year 2 IL-12p70 was negatively 
associated with age (t= -3.07, p < .01), and at year 3 the negative relation between IL-2 and age 
reached significance (t = -2.22, p = .03). Also, in year 3 serum concentrations of IL-1β were 
significantly positively associated with salivary concentrations of IL-1β (t = 2.30, p = .02) after 
adjusting for age, smoking status, and salivary adiponectin levels.  
------------------------------------------- 
Insert Table 7 about here 
------------------------------------------- 
Discussion 
To the best of our knowledge, this is the first study to rigorously examine serum-saliva 
cytokines among healthy adolescents. The findings provide important information about salivary 
cytokines’ measurement and concentrations, intercorrelations, stability, and associations with 
individual factors and other analytes, including serum-saliva correlations. Measurement and 
concentrations: The results reveal that levels of cytokines, except IFNγ and IL-10, were 
detectable in the majority of saliva samples, but that the distributions of salivary cytokines were 
non-normal in every case. The levels of all cytokines were lower in saliva than serum, except IL-
8 and IL-1ß. Salivary levels for these two cytokines were more than 20-times higher than other 
salivary cytokines. Intercorrelations: The intercorrelations between cytokines in saliva were 
higher than in serum, and the factor structure in saliva was also distinct from that in serum with a 
single component explaining individual differences in the salivary cytokines. Stability across 
time: Cytokine levels were more stable across years when measured in serum than in saliva. 
Cytokine associations with individual factors and other analytes: Using adiponectin as a marker 
of oral health, there were strong associations between salivary adiponectin and salivary, but not 
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serum, cytokines. Some of the salivary cytokines were inversely associated with age and pubertal 
stage. Cytokine serum-saliva association: Surprisingly, only IL-1ß showed a significant serum-
saliva correlation, and, although statistically significant, the magnitude of the association was 
negligible. Also, this finding was not consistent across assessment years and only revealed in 
hierarchical regressions after controlling for age, adiponectin, and smoking status. Overall the 
findings suggest that variation in basal salivary cytokine levels in healthy adolescents largely 
reflects compartmentalized local inflammatory activity of the oral mucosal immune system.  
At the practical measurement level, for the majority of saliva samples, the cytokine 
values fell within the dynamic range of measurement afforded by the MSD multi-plex 
electrochemoluminescence immunoassay platform. For salivary IFNγ and IL-10, however, levels 
were below the detection limit (< 1.0 pg/mL) for the majority of the samples and consistently so 
across the assessment years. This observation highlights the possibility that it may not be 
worthwhile to include measures of IFNγ and IL-10 in future studies of salivary cytokines in 
healthy girls. Also, the distributions of all cytokines in saliva were non-normal. Therefore, the 
salivary cytokine data required intensive restructuring and transformation so as not to violate 
assumptions of normality in statistical analyses. The description of these atypical distributions 
has important implications for estimating statistical power when planning studies, how salivary 
cytokine data are prepared prior to data analyses (i.e., transformation and dealing with statistical 
outliers), as well as for the selection of appropriate parametric or non-parametric statistical 
techniques.  
Serum levels of cytokines were higher than levels in saliva for all cytokines except IL-1ß 
and IL-8. Levels of IL-1ß and IL-8 were more than 20-25-times the levels of the other salivary 
cytokines. The literature on oral immunology suggests that IL-8 is a chemotactic factor that 
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influences the migration of neutrophils and increases their concentration (Bickel, 1993). Also, 
IL-1ß is important for the activation of neutrophils (Shaftel, Carlson, Olschowka, Kyrkanides, 
Matousek,   & O’Banion, 2007; Struyf, Coillie, Paemen, Put, Lenaerts, Proost, Opdenakker, & 
Van Damme, 1998). Neutrophils are the most prevalent type of phagocyte in circulation and in 
whole saliva (Raeste, 1972). Their granules contain proteins, proteolytic enzymes, defensins, and 
myeloperoxidases that kill bacteria, break down bacterial proteins and cell walls, and stimulate 
phagocytosis of IgG-coated bacteria (see Kindt et al., 2006). The oral compartment is home to 
hundreds of species of bacteria, and the migration and activation of neutrophils plays a major 
role in promoting and maintaining oral health. The high levels of IL-8 and IL-1β observed in the 
current study likely reflect this important role of neutrophils in oral health. 
On average, the correlations between the various cytokines in saliva were higher than the 
intercorrelations among the same cytokines when measured in serum. This pattern was consistent 
across assessment year and was more pronounced for IL-12p70, IL-1ß, IL-2 and IL-6. The PCA 
findings confirm two principal components that explain the majority (~75%) of the variance in 
cytokines when measured in serum. By contrast, there was just a single component to the 
structure of the variation in cytokines when they are measured in saliva. Moreover, the 
intracorrelations for each cytokine over time were stronger for cytokines measured in serum than 
in saliva, and there was only negligible evidence of any serum-saliva correlation. Oral biologists 
consider the mouth the most complex microbial microenvironment in the body (Giannobile, 
Beikler, Kinney,Ramseier, Morelli, & Wong, 2009; Zhang, Henson, Camargo, & Wong, 2009). 
The oral mucosa immune system is exposed to a wide variety of non-self antigens including 
bacteria, fungi, virus, and toxins. Thus, in contrast to circulating blood, oral fluid is not sterile. It 
is tempting to speculate that because of compartmentalized host-microbe interactions salivary 
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cytokines reflect a variable environmental microbial influence in the oral compartment, 
compared to invariant host genetic influences on serum cytokines in these healthy adolescents in 
the sterile serum compartment. Collectively the findings of the study suggest that 
compartmentalized cytokine activity in the mouth of healthy individuals may be more 
pronounced and variable than in the systemic immune system.  
All salivary cytokines were strongly associated with salivary adiponectin. Studies suggest 
that adiponectin may play a role in maintaining periodontal health (Iwayama et al., 2012). The 
fact that all salivary, but not serum, cytokine levels were correlated with adiponectin and that 
these correlations were very strong is particularly noteworthy. We interpret these finding as 
confirmatory evidence that salivary cytokine levels largely reflect the degree of local oral, rather 
than systemic, inflammation; a point crucial for developmental scientists.  
   There were no associations between serum and saliva levels of cytokines. It is especially 
important to note that this was largely true even after controlling for adiponectin and smoking 
status. The fact that only IL-1ß showed an association with serum should not go unnoticed. As 
noted above, serum levels of IL-1ß play a major role in communication within and across the 
NEI (Smith, 1992, Weiss et.al, 1994). It could be that in the case of systemic inflammation (e.g., 
sepsis, fever, infection), the serum-saliva association for IL-1ß would have been stronger and 
more consistent across assessment years. Interestingly, studies show that IL-1ß released by cells 
in the gingival crevicular gap (the space between the gum line and the tooth) during the course of 
periodontal disease moves into circulation and stimulates the liver to secrete C-reactive protein 
(CRP) (Megson, Fitzsimmons, Dhamapatri, & Bartold, 2010). At least one study suggests 
modest serum-saliva correlations for CRP (Out, Hall, Granger, Page, & Woods, 2012; see also 
Floriano, Christodoulides, Miller, Ebersole, Spertus, Rose, Kinane, Novak, Steinhubl, Acosta, 
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Mohanty, Dharshan, Yeh, Redding, Furmaga, &  McDevitt, 2009; Punyadeera, Dimeski, 
Kostner, Beyerlein, & Cooper-White, 2011; Quellet-Morin, Danese, Williams, & Arseneault, 
2011). It is possible that salivary IL-1β may play a role in communication across and within the 
NEI. The next generation of studies might explore these serum-saliva relationships in special 
circumstances and cases representing confirmed systemic and oral inflammatory disease, or both. 
For instance, in early childhood when the rate of oral health problems is so low, do levels of 
salivary cytokines more accurately reflect levels in the circulation? What about disease states 
where the levels of cytokines in blood are atypically high, is the serum-saliva association during 
these special physiological circumstances stronger? How do salivary cytokines respond to 
challenge: can similar stress-reactivity patterns be observed in salivary cytokines as for serum 
cytokines?  
 Interestingly, both age and pubertal stage were associated with salivary cytokine levels. 
Older and more pubertally mature girls had lower levels of most salivary cytokines, particularly 
in assessment years 1 and 2. These findings raise the possibility that inflammation in the oral 
mucosa is associated with hormonal changes associated with girls’ pubertal transition. For 
instance, studies show the rate of inflammatory autoimmune diseases to be higher in females 
than males, and implicate differences in estradiol levels as a mechanism partially responsible for 
this robust gender difference (Fairweather, Frisancho-Kiss, & Rose, 2008). Unfortunately, 
pubertal relations with salivary cytokine levels could not be fully explored in this sample, 
because the range in pubertal stage was very restricted, particularly at assessment year 3 (i.e., 
most girls were in advanced pubertal stages). Studies also suggest that the rate of oral 
inflammation increases substantially as children transition through puberty (Guncu, Tozum, & 
Caglayan, 2005; Oh, Eber, & Wang, 2002). The lack of age and puberty effects at assessment 
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year 3 may be due to smoking in our sample. Older and more pubertally mature girls were more 
likely to smoke, and therefore, they are more likely to have compromised oral health (Heikkinen, 
Pajukanta, Pitkaniemi, Broms, Sorsa, Koskenvuo, & Meurman, 2008; Heikkinen, Pitkaniemi, 
Kari, Pajukanta, Elonheimo, Koskenvuo, & Meurman, 2012; Lee, Taneja, & Vassallo, 2012; 
Azar & Richard, 2011). Poorer oral health may be especially pronounced at the third assessment 
year when the sample is the oldest. Although the sample size within each age group was too 
small to adequately test the effect of smoking on salivary cytokine levels, it is possible that the 
effects of age and puberty at year 3 were masked by smoking-related changes in salivary 
cytokine concentrations. Larger studies that follow girls (and boys) through this developmental 
phase and monitor reproductive hormones and salivary cytokines might prove important for 
understanding risk for periodontal disease in adolescence.  
In conclusion, cytokines in saliva show different levels, stability, inter-relationships, and 
associations with oral health than serum cytokines. There is little evidence of a serum-saliva 
association under conditions of general health. Collectively, the pattern of findings suggests that 
basal levels of salivary cytokines reflect activity of a highly compartmentalized oral mucosal 
immune system. In these circumstances, the value of salivary cytokines to the study of brain, 
behavior and immunity may be questionable. Future studies may examine whether this is also 
true in other physiological states, developmental stages and stressed versus resting conditions. 
The observed variation in salivary cytokines in these circumstances may be more likely to reflect 
systemic processes and be reliably associated with child development, behavior and health. In 
the current study, focusing on a healthy and non-stressed sample of adolescent girls, the findings 
of our study highlight the importance of measuring salivary cytokines to advance our 
understanding of risk for oral health and disease during adolescence and raise important 
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questions about the role of salivary cytokines in intracellular and hormonal signaling within the 
larger NEI network. 
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Table 1. Descriptive statistics of non-transformed salivary cytokines in healthy adolescent girls at each assessment year (pg/mL) 
 M SD Min Max Median 25th percentile 75th percentile 
Year 1        
  IFNγ 1.14 1.89 0.00 6.96 0.00 0.00 3.14 
  IL-10 0.35 1.10 0.00 10.09 0.00 0.00 0.00 
  IL-12p70 0.74 1.03 0.00 7.62 0.61 0.00 0.97 
  IL-1β 75.84 88.44 1.54 530.61 51.92 23.11 85.59 
  IL-2 1.76 1.40 0.00 6.92 1.43 0.76 2.21 
  IL-6 1.40 3.27 0.00 27.12 0.68 0.36 1.18 
  IL-8 61.26 63.13 0.43 316.86 43.16 17.76 79.29 
  TNFα 0.90 1.07 0.00 5.77 0.78 0.00 1.35 
  GM-CSF 3.25 3.45 0.00 17.36 1.96 0.95 4.01 
Year 2        
  IFNγ 1.94 2.78 0.00 12.20 0.00 0.00 3.69 
  IL-10 0.18 0.55 0.00 3.45 0.00 0.00 0.00 
  IL-12p70 0.49 0.74 0.00 5.48 0.51 0.00 0.72 
  IL-1β 69.88 105.91 1.67 913.53 35.82 19.05 95.56 
  IL-2 1.57 1.96 0.00 14.41 0.99 0.55 1.95 
  IL-6 0.89 1.72 0.00 13.03 0.46 0.31 0.66 
  IL-8 54.95 107.25 1.87 816.83 25.50 10.76 56.92 
  TNFα 0.65 0.92 0.00 4.59 0.58 0.00 0.93 
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  GM-CSF 2.44 3.36 0.00 26.47 1.34 0.74 3.09 
Year 3        
  IFNγ 1.71 2.24 0.00 7.44 0.00 0.00 3.56 
  IL-10 0.44 0.88 0.00 6.49 0.00 0.00 1.03 
  IL-12p70 0.63 0.76 0.00 5.25 0.59 0.00 0.87 
  IL-1β 66.18 63.54 4.37 310.25 46.07 21.86 82.23 
  IL-2 1.70 2.51 0.00 25.60 1.29 0.72 2.03 
  IL-6 1.04 2.51 0.00 24.29 0.54 0.30 0.98 
  IL-8 50.16 44.24 0.83 186.77 35.23 16.93 69.49 
  TNFα 0.87 0.90 0.00 5.99 0.78 0.00 1.28 
  GM-CSF 2.55 2.37 0.00 11.37 1.79 1.03 2.87 
Note. Descriptive statistics were calculated across cohorts. N = 113 for year 1, N = 114 for year 2, N = 107 for year 3.  
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Table 2. Descriptive statistics of non-transformed serum cytokines in healthy adolescent girls at each assessment year (pg/mL) 
 M SD Min Max Median 25th percentile 75th percentile 
Year 1        
  IFNγ 9.60 46.34 0.00 411.78 0.00 0.00 2.90 
  IL-10 32.93 120.17 0.00 1127.08 7.17 3.91 11.97 
  IL-12p70 30.04 115.13 0.00 1001.60 1.35 0.00 6.83 
  IL-1β 12.28 43.61 0.00 417.37 1.88 0.00 6.05 
  IL-2 19.34 62.37 0.00 613.79 5.44 1.14 11.17 
  IL-6 10.35 27.12 0.00 173.81 1.41 0.71 4.35 
  IL-8 8.09 7.49 0.00 62.42 6.92 4.94 9.02 
  TNFα 9.75 7.56 0.70 51.70 8.60 6.06 10.98 
  GM-CSF 98.91 285.31 0.00 2353.39 16.40 0.00 65.35 
Year 2        
  IFNγ 3.37 17.36 0.00 172.78 0.00 0.00 0.67 
  IL-10 17.72 53.17 0.37 506.25 6.28 4.26 11.42 
  IL-12p70 12.70 49.77 0.00 467.98 0.59 0.00 5.42 
  IL-1β 9.83 53.07 0.00 558.43 1.17 0.00 4.20 
  IL-2 13.99 67.94 0.00 720.55 3.60 0.63 9.00 
  IL-6 7.31 26.19 0.00 244.17 1.76 0.96 4.32 
  IL-8 7.36 6.34 1.49 64.69 6.36 4.99 7.79 
  TNFα 8.32 4.27 2.02 27.73 7.52 5.29 10.26 
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  GM-CSF 79.03 336.62 0.00 3493.67 0.00 0.00 54.45 
Year 3        
  IFNγ 187.04 349.14 0.00 1688.08 53.02 5.44 197.28 
  IL-10 52.94 307.86 0.00 2872.73 2.99 1.45 8.20 
  IL-12p70 266.86 887.06 0.00 5276.33 7.37 1.06 44.73 
  IL-1β 10.96 60.92 0.00 584.28 0.33 0.00 2.62 
  IL-2 30.33 111.41 0.00 694.30 2.16 0.32 9.23 
  IL-6 38.62 96.83 0.00 560.63 7.48 1.54 20.57 
  IL-8 54.39 74.84 3.75 319.26 24.07 9.21 57.02 
  TNFα 17.29 42.28 2.24 362.34 8.05 5.69 12.79 
  GM-CSF 55.82 264.95 0.00 2187.26 0.00 0.00 11.14 
Note. Descriptive statistics were calculated across cohorts. N = 113 for year 1, N = 114 for year 2, N = 107 for year 3.  
  
46 
 
Table 3. Intercorrelations within salivary cytokines and within serum cytokines at the first assessment year, controlling for age. 
 IL-12p70 IL-1β IL-2 IL-6 IL-8 TNFα GM-CSF 
IL-12p70 ------- .58** .61** .89** .33** .22* .50** 
IL-1β .54** ------- .82** .48** .37** .35** .76** 
IL-2 .77** .75** ------- .49** .36** .31** .75** 
IL-6 .57** .51** .63** ------- .31** .20* .39** 
IL-8 .71** .72** .93** .61** ------- .53** .39** 
TNFα .66** .57** .65** .54** .66** ------- .24* 
GM-CSF .75** .71** .91** .68** .89** .65** ------- 
Note. Partial correlations for the salivary cytokines can be found below the diagonal; the serum correlations are presented above the 
diagonal. *p<.05, **p < .01. N=113 
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Table 4. Correlations of cytokine concentrations over time in serum and saliva, controlling for age. 
 Serum  Saliva 
 Years 1 and 2 Years 2 and 3 Years 1 and 3  Years 1 and 2 Years 2 and 3 Years 1 and 3 
IL-12p70 .72** .49** .41**  .24** .09 .22* 
IL-1β .75** .29** .45**  .37** .36** .46** 
IL-2 .73** .54** .57**  .31** .26** .31** 
IL-6 .70** .40** .50**  .21* .30** .19 
IL-8 .53** .17 .16  .38** .28** .45** 
TNFα .39** .10 .29**  .33** .18 .35** 
GM-CSF .53**   .29** .39**  .25** .28** .43** 
Note. Years 1 and 2, N=113; years 2 and 3, N=107; years 1 and 3, N=106. *p < .05, **p < .01. 
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Table 5. Correlations of serum and salivary cytokines with adiponectin for the first assessment year, controlling for age. 
 Serum Saliva 
IL-12p70 -.08 .51** 
IL-1β -.01 .77** 
IL-2 .00 .69** 
IL-6 -.01 .62** 
IL-8 -.07 .71** 
TNFα .00 .46** 
GM-CSF -.05 .68** 
Note. N= 113. ** p < .01 
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Table 6. Correlations between salivary and serum cytokines at the first assessment year, controlling for age. 
 Correlation with 
serum levels 
IL-12p70 -.11 
IL-1β .11 
IL-2 -.01 
IL-6 .07 
IL-8 -.05 
TNFα -.08 
GM-CSF -.07 
Note: N = 113  
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Table 7. Regression analyses for each cytokine predicting salivary levels from serum levels, controlling for age, adiponectin and 
smoking (first assessment year) 
  B SE β t p R2 F 
IL-12p70 Step 1      0.31 19.30** 
   Age  -0.01 0.01 -.12 -1.27 .21   
   Adiponectin 0.13 0.02 .49 7.03 <.01   
   Smoking -0.07 0.05 -.12 -1.33 .19   
 Step 2      0.32 14.59** 
   Serum levels -0.01 0.01 -.06 -0.87 .39   
IL-1β Step 1      0.60 61.12** 
   Age  -0.03 0.03 -.07 -1.01 .32   
   Adiponectin 0.92 0.07 .76 12.80 <.01   
   Smoking -0.05 0.16 -.02 -0.28 .78   
 Step 2      0.61 48.48** 
   Serum levels 0.11 0.07 .12 1.61 .11   
IL-2 Step 1      0.52 51.78** 
   Age  -0.03 0.01 -.16 -1.96 .05   
   Adiponectin 0.27 0.02 .66 11.58 <.01   
   Smoking -0.06 0.06 -.07 -0.89 .38   
 Step 2      0.52 39.58** 
   Serum levels 0.00 0.02 -.01 -0.09 .93   
IL-6 Step 1      0.44 19.56** 
   Age  -0.02 0.01 -.12 -1.04 .17   
   Adiponectin 0.23 0.03 .60 7.08 <.01   
   Smoking -0.09 0.05 -.12 -1.87 .06   
 Step 2      0.45 14.42** 
   Serum levels 0.02 0.02 .08 0.96 .34   
IL-8 Step 1      0.55 74.03** 
   Age  -0.09 0.04 -.19 -2.35 .02   
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   Adiponectin 0.79 0.05 .68 14.73 <.01   
   Smoking -0.15 0.19 -.07 -0.79 .43   
 Step 2      0.55 60.38** 
   Serum levels -0.01 0.12 -.01 -0.12 .91   
TNFα Step 1      0.29 25.27** 
   Age  -0.04 0.01 -.26 -2.63 .01   
   Adiponectin 0.16 0.03 .44 5.80 <.01   
   Smoking -0.01 0.08 -.02 -0.15 .88   
 Step 2      0.29 18.88** 
   Serum levels -0.06 0.08 -.08 -0.73 .47   
GM-CSF Step 1      0.56 50.83** 
   Age  -0.06 0.02 -.24 -3.43 <.01   
   Adiponectin 0.40 0.04 .61 11.03 <.01   
   Smoking -0.19 0.08 -.15 -2.46 .02   
 Step 2      0.56 40.07** 
   Serum levels -0.01 0.02 -.04 -0.66 .51   
 Note. The statistics are derived from the second step of each regression model. N = 113, **p < .01 
 
